Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-10-16
2000-05-30
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
314247, 544224, 5483561, A61K 31415, A61P 3708, C07D23104
Patent
active
060691638
ABSTRACT:
Azapeptide acids of Formula I are antagonists of VLA-4 and/or .alpha..sub.4 .beta..sub.7, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of asthma, allergies, inflammation, multiple sclerosis, and other inflammatory and autoimmune disorders.
REFERENCES:
patent: 4431659 (1984-02-01), Sakai et al.
Bioorganic & Medicinal Chem Letters vol. 6 No. 21 pp. 2495-2500, 1996.
Med. Chem. 1997, 40, 3359-3368.
Bioorganic Med. Chem. Letter vol. 8, 2297 (1998).
Merck & Co. , Inc.
Ramsuer Robert W.
Rose David L.
Yang Mollie M.
LandOfFree
Azapeptide acids as cell adhesion inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azapeptide acids as cell adhesion inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azapeptide acids as cell adhesion inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1910718